Commonly used muscle relaxant therapies for acute low back pain: A review of carisoprodol, cyclobenzaprine hydrochloride, and metaxalone

Clinical Therapeutics

Volumn 26, Issue 9, 2004, Pages 1355-1367

  Toth, Peter E ^a,b   Urtis, Jason ^c  

^a UNIVERSITY OF ILLINOIS   (United States)

^b IL 61081 ^*  (United States)

^c Texas USA   (United States)

Author keywords

carisoprodol; cyclobenzaprine hydrochloride; low back pain; metaxalone; muscle relaxants; randomized controlled trials; substance related disorders

Indexed keywords

CARISOPRODOL; CYCLOBENZAPRINE; CYCLOOXYGENASE 2 INHIBITOR; IBUPROFEN; METAXALONE; MUSCLE RELAXANT AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PLACEBO;

ATAXIA; CENTRAL NERVOUS SYSTEM; CLINICAL TRIAL; COCHRANE LIBRARY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA BASE; DIZZINESS; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG EFFICACY; DRUG SAFETY; EMBASE; FATIGUE; FINANCIAL MANAGEMENT; GASTROINTESTINAL DISEASE; HEADACHE; HUMAN; IRRITABILITY; LOW BACK PAIN; MEDICAL LITERATURE; MEDLINE; MUSCLE SPASM; NAUSEA; NERVOUSNESS; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK FACTOR; SEDATION; SOMNOLENCE; TREMOR; VERTIGO; VOMITING; XEROSTOMIA;

EID: 9644291924     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2004.09.008     Document Type: Article

References (49)

1. Available at MEDLINE Plus Medical encyclopedia: Back pain--low Accessed August 3, 2004
2. Hart L.G., Deyo R.A., and Cherkin D.C. Physician office visits for low back pain. Frequency, clinical evaluation, and treatment patterns from a U.S. national survey Spine 20 1995 11 19
3. Blount B.W., Hart G., and Ehreth J.L. A description of the content of Army family practice J Am Board Fam Pract 6 1993 143 152
4. Bigos S., Bowyer O., and Braen G. Clinical Practice Guideline Number 14: Acute Low Back Problems in Adults AHCPR publication 95-0642 1994 Agency for Health Care Policy and Research, Public Health Service, US Department of Health and Human Services Rockville, Md
5. van Tulder M.W., Touray T., and Furlan A.D. Muscle relaxants for nonspecific low back pain: A systematic review within the framework of the Cochrane Collaboration Spine 28 2003 1978 1992
6. Frymoyer J.W., and Cats-Baril W.L. An overview of the incidences and costs of low back pain Orthop Clin North Am 22 1991 263 271
7. [published correction appears in MMWR Wkly. 2001;50:149] Prevalence of disabilities and associated health conditions among adults--United States, 1999 MMWR Wkly 50 2001 120 125
8. Stewart W.E., Ricci J.A., and Chee E. Lost productive time and cost due to common pain conditions in the US workforce JAMA 290 2003 2443 2454
9. Cailliet R. Pain: Mechanisms, assessment, and management Soft Tissue Pain and Disability 3rd ed. 1996 Davis Philadelphia, Pa 14 59
10. Cailliet R. The muscle component of soft tissue function and pain Soft Tissue Pain and Disability 3rd ed. 1996 Davis Philadelphia, Pa 60 83
11. Bosworth T. Special report. The proper use of muscle relaxants in musculoskeletal pain management Prim Care Spec Ed 6 2002 1 8
12. Cady R., Farmer K., and Schreiber C. Special report. Skeletal muscle relaxants: A new rationale for choice Prim Care Spec Ed 7 2003 1 4
13. Deyo R.A., Rainville J., and Kent D.L. What can the history and physical examination tell us about low back pain? JAMA 268 1992 760 765
14. Frymoyer J.W. Back pain and sciatica N Engl J Med 318 1988 291 300
15. Nachemson A.L. The lumbar spine: An orthopaedic challenge Spine 1 1976 59 71
16. Low back pain red flag. Family Practice Notebook Web site August 3, 2004
17. Gillette R.D. A practical approach to the patient with back pain Am Fam Phys 53 1996 670 676
18. Gillette R.D. A practical approach to the patient with back pain Am Fam Phys 53 1996 683 684
19. Connelly C. Patients with low back pain: How to identify the few who need extra attention Postgrad Med 100 1996 143 150
20. Connelly C. Patients with low back pain: How to identify the few who need extra attention Postgrad Med 100 1996 155 156
21. Hagglund S. Primary care approach to low back pain: The good, the bad, and the ugly Phys Assistant 24 2000 31 41
22. Deyo R.A., Diehl A.K., and Rosenthal M. How many days of bed rest for acute low back pain? N Engl J Med 315 1986 1064 1070
23. Patel A.T., and Ogle A.A. Diagnosis and management of acute low back pain Am Fam Phys 61 2000 1779 1786
24. Patel A.T., and Ogle A.A. Diagnosis and management of acute low back pain Am Fam Phys 61 2000 1789 1790
25. Cailliet R. Low back pain Soft Tissue Pain and Disability 3rd ed. 1996 Davis Philadelphia, Pa 101 170
26. Burton A.K., and Erg E. Back injury and work loss. Biomechanical and psychosocial influences Spine 22 1997 2575 2580
27. Treatment of acute back pain: An interdisciplinary approach. American Academy of Neurological and Orthopaedic Surgeons Web site June 8, 2004
28. Physicians' Desk Reference 58th ed. 2004 Thomson PDR Montvale, NJ
29. Hindle T.H. III Comparison of carisoprodol, butabarbital, and placebo in treatment of the low back syndrome California Med 117 1972 7 11
30. Boyles W.E., Glassman J.M., and Soyka J.P. Management of acute musculoskeletal conditions: Thoracolumbar strain or sprain. A double-blind evaluation comparing the safety and efficacy of carisoprodol with diazepam Today's Ther Trends 1 1983 1 16
31. Rollings H.E., Glassman J.M., and Soyka J.P. Management of acute musculoskeletal conditions--thoracolumbar strain or sprain: A double-blind evaluation comparing the safety and efficacy of carisoprodol with cyclobenzaprine hydrochloride Curr Ther Res Clin Exp 34 1983 917 928
32. Littrell R.A., Hayes L.R., and Stillner V. Carisoprodol (Soma): A new and cautious perspective on an old agent South Med J 86 1993 753 756
33. Reeves R.R., Carter O.S., and Pinkofsky H.B. Carisoprodol (Soma): Abuse potential and physician unawareness J Addict Dis 18 1999 51 56
34. Alabama Administrative Code. (4) Schedule IV January 16, 2004
35. Available at Douma A. Your guide to choosing a skeletal muscle relaxant Accessed January 16, 2004 09
36. Available at Erowid Carisoprodol (Soma) legal status Accessed January 16, 2004
37. Legislature of the State of Idaho Health and Welfare Committee. House Bill No. 103 2001
38. Minnesota Senate Senate schedule for the week of February 7-11 January 16, 2004 Available at Accessed
39. Available at Angarola R.T., and Joranson D.E. State controlled-substances laws and pain control Accessed January 16, 2004
40. WSR 03-09-124: Preproposal statement of inquiry Washington State Register Web site January 16, 2004
41. Prescription drug addiction: The hidden epidemic January 15, 2004
42. Borenstein D.G., and Korn S. Efficacy of a low-dose regimen of cyclobenzaprine hydrochloride in acute skeletal muscle spasm: Results of two placebo-controlled trials Clin Ther 25 2003 1056 1073
43. 2 receptors Eur J Pharmacol 458 2003 91 99
44. Katz W.A., and Dube J. Cyclobenzaprine in the treatment of acute muscle spasm: Review of a decade of clinical experience Clin Ther 10 1988 216 228
45. Nibbelink D.W., and Strickland C.C. Cyclobenzaprine (Flexeril™): Report of a postmarketing surveillance program Curr Ther Res Clin Exp 28 1980 894 903
46. Fathie K. A second look at a skeletal muscle relaxant: A double-blind study of metaxalone Curr Ther Res Clin Exp 6 1964 677 683
47. Dent R.W., and Ervin D.K. A study of metaxalone (Skelaxin®) vs. placebo in acute musculoskeletal disorders: A cooperative study Curr Ther Res Clin Exp 18 1975 433 440
48. Average Wholesale Price: Facts and Comparisons 2002 Medi-Span St. Louis, Mo
49. Prescription drug guide: Your guide to evaluating prescription drug costs and effectiveness August 13, 2004